Loading
NASDAQHealthcareMedical - Devices
Latest quote
$21.65
−$0.11 · -0.51%
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Previous close
$21.65
−$0.11 · -0.51%
Regular session · ET · Market data may be delayed.
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Day range
Current $21.65
52-week range
Current $21.65
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
47
Fair Value
Sentiment
62
Bullish
Risk
43
Elevated Risk
Momentum
53
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Day range
Current $21.65
52-week range
Current $21.65
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 236.35M USD | 204.73M USD | 148.73M USD | 122.29M USD | 98.05M USD |
| Cost of goods sold | 63.69M USD | 56.13M USD | 37.48M USD | 31.63M USD | 24.65M USD |
| Gross profit | 172.66M USD | 148.6M USD | 111.25M USD | 90.66M USD | 73.4M USD |
| Research and development | 9.1M USD | 11.03M USD | 10.9M USD | 8.45M USD | 5.54M USD |
| Selling, general, and administrative | 192.56M USD | 167.09M USD | 126.12M USD | 104M USD | 85.73M USD |
| Operating expenses | 201.66M USD | 178.12M USD | 138M USD | 116.06M USD | 91.43M USD |
| Interest income | — | — | 198K USD | — | — |
| Interest expense | 6M USD | 2.62M USD | — | 2.42M USD | 2.25M USD |
| Depreciation and amortization | 21.12M USD | 19.08M USD | 17.39M USD | 13.1M USD | 10.68M USD |
| Operating income | −29M USD | −29.52M USD | −26.75M USD | −25.4M USD | −18.02M USD |
| Net income | −39.65M USD | −37.82M USD | −20.97M USD | 1.26M USD | −16.26M USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$25.25
16.63% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI12.45M0.00%2.3T USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM10.13M0.01%78.27B USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF4.67M0.00%95.4B USD0.05%$235+0.80%
Dimensional - US Small Cap ETFDFAS3.22M0.01%33.87B USD0.31%$78.35+0.32%
Vanguard Russell 2000 ETFVTWO2.37M0.01%18B USD0.06%$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA1.99M0.01%21.73B USD0.03%$32.79+0.40%
Dimensional - US Core Equity 2 ETFDFAC1.71M0.00%88.6B USD0.21%$45.33+0.49%
U.S. Micro Cap Portfolio ETFDFMC1.52M0.02%7.56B USD0.43%$57.813+0.20%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHADimensional - US Core Equity 2 ETFDFACU.S. Micro Cap Portfolio ETFDFMCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
